메리트 메디컬 시스템즈 (MMSI) 회사 소개
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy.
The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems.
It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems.
In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures.
It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
Merit Medical Systems, Inc.는 단회용 의료기기를 설계·개발·제조·판매하며 미국, 중국, 일본, 독일, 프랑스, 영국 등 전 세계 시장에서 인터벤셔널·진단·치료 절차에 사용되는 제품을 공급합니다.
회사는 Cardiovascular 및 Endoscopy 두 개의 세그먼트로 운영되며, micropuncture kits, angiographic needles, sheaths, guide wires, safety products 등을 포함한 기초 제품부터 peripheral intervention products(angiography, drainage, delivery systems, embolotherapy products), oncology products(soft tissue biopsy products 및 액세서리), cardiac intervention products(cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, intervention products), spine products(vertebral augmentation, radiofrequency ablation, bone biopsy systems)까지 폭넓게 제공합니다. 또한 custom procedural solutions(critical care products, syringes, manifold kits, trays and packs), medical tubes and wires에 대한 coating services, microelectromechanical systems용 sensor components도 제공합니다.
이밖에 gastroenterology 제품(esophageal stents, cryoballoon and inflation devices, gauges, balloon dilators), pulmonary 제품(laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems) 및 endoscopy·bronchoscopy용 kits and accessories를 취급합니다. 제품은 병원, 대체 진료 현장의 의사, 기술자 및 간호사에게 direct sales force, independent distributors, original equipment manufacturer partners, custom procedure tray manufacturers를 통해 판매되며, 캐나다, 서유럽, 호주, 브라질, 말레이시아, 대한민국, 아랍에미리트, 인도, 뉴질랜드, 남아프리카공화국 등으로 수출합니다. Merit Medical Systems, Inc.는 1987년에 법인 설립되었으며 본사는 유타주 South Jordan에 위치해 있습니다.
주소: 1600 West Merit Parkway, South Jordan, UT 84095, United States
전화번호: 801 253 1600
웹사이트: https://www.merit.com
섹터: Healthcare
산업: Medical Instruments & Supplies
직원 수: 7,500
MMSI STOCK CHART
MMSI 주가 차트 (1년)
메리트 메디컬 시스템즈 MMSI LATEST NEWS
최신뉴스: 9월 4일MMSI LATEST NEWS
메리트 메디컬 시스템즈 최신 뉴스
메리트 메디컬 시스템즈 관련 주요 소식과 시장 반응
최근 배당 정보Finviz Dividend Snapshot
| 항목 | 값 |
|---|---|
| Dividend Est. | 해당 없음 |
| Dividend TTM | 해당 없음 |
| Dividend Ex-Date | 해당 없음 |
| Dividend Gr. 3/5Y | - - |
| Payout | 0.00% |
| P/E | 35.19 |
MMSI TARGET PRICE 2026
MMSI TARGET PRICE
MMSI 목표주가
| 날짜 | 의견 | 애널리스트 | 투자의견 | 목표가 변경 |
|---|---|---|---|---|
| Feb-26-26 | 하향Downgrade | Wells Fargo | Overweight → Equal Weight | $78 |
| Feb-06-26 | 신규Initiated | BTIG Research | 매수 Buy | $107 |
| Mar-28-25 | 신규Initiated | JP Morgan | 비중확대 Overweight | $120 |
| Dec-11-24 | 상향Upgrade | Wells Fargo | Equal Weight → Overweight | $103 → $120 |
| Jun-28-24 | 신규Initiated | Robert W. Baird | 시장수익률상회 Outperform | $96 |
| Apr-11-24 | 신규Initiated | CL King | 매수 Buy | $88 |
| Feb-07-24 | 신규Initiated | BofA Securities | 중립 Neutral | $87 |
| Dec-21-23 | 상향Upgrade | Canaccord Genuity | Hold → Buy | $100 |
| Dec-20-22 | 하향Downgrade | Canaccord Genuity | Buy → Hold | $73 → $72 |
| Jan-05-21 | 상향Upgrade | Needham | Hold → Buy | $65 |
| Sep-28-20 | 상향Upgrade | Wells Fargo | Underweight → Equal Weight | $42 |
| Feb-25-20 | 하향Downgrade | Barrington Research | Outperform → Mkt Perform | |
| Feb-03-20 | 상향Upgrade | Raymond James | Mkt Perform → Outperform | $43 |
| Dec-12-19 | 하향Downgrade | Wells Fargo | Market Perform → Underperform | $26 |
| Sep-24-19 | 신규Initiated | Oppenheimer | 시장수익률상회 Outperform | |
| Sep-10-19 | 하향Downgrade | Raymond James | Outperform → Mkt Perform | |
| Jul-26-19 | 하향Downgrade | Wells Fargo | Outperform → Market Perform | |
| Jul-26-19 | 하향Downgrade | Needham | Buy → Hold | |
| Oct-02-18 | 의견유지Reiterated | Needham | 매수 Buy | $67 → $73 |
| Aug-07-18 | 하향Downgrade | BofA/Merrill | Buy → Underperform |
✍️ 최근 5일 MMSI 차트분석
메리트 메디컬 시스템즈 (MMSI) 차트분석
메리트 메디컬 시스템즈의 최근 5일 흐름, 단기 매물대, 이동평균 저항/지지와 시뮬레이션 차트는 별도 차트분석 페이지에서 확인할 수 있습니다.
차트분석 페이지 보기메리트 메디컬 시스템즈 (MMSI) 최근 실적발표
메리트 메디컬 시스템즈의 EPS, 매출, 실적 발표일과 관련 차트는 내부 실적발표 페이지에서 확인할 수 있습니다.
실적발표 페이지 보기


